Eric is a partner at Reed Smith LLP, and a member of the Life Sciences Health Industry Group, practicing primarily in the area of product liability litigation for pharmaceutical and medical device companies. Eric’s practice has particularly focused on scientific, medical and regulatory issues in product liability cases, including expert discovery, Daubert motions, and preemption issues. In addition to pharmaceutical and medical device product liability litigation, he has worked on commercial disputes, False Claims Act cases, disability insurance and personal injury cases involving food and beverage products and he has counselled clients on a range of issues, including product labeling and risk minimization. He has worked on cases involving a wide range of products and issues with cases pending in courts in the United States and discovery taken around the world.
In his extensive experience, Eric has personally tried multiple prescription drug and device cases to verdict and assisted in trying many other prescription drug and medical device cases. In addition to preparing numerous prescription drug and medical device cases for trial, he has taken and defended more than one thousand fact and expert witness depositions and developed novel case theories and defenses. Also, he has drafted and argued numerous discovery, Daubert, in limine, and dispositive motions, along with post-trial motions and appellate briefs. In addition, Eric has supervised teams of associates and paralegals with responsibility for more than 50,000 cases in state and federal courts around the country. In all, he has participated in a range of roles during the life of a serial product liability litigation, as national, regional, local, and trial counsel. He has been centrally involved in paper and electronic document sweeps and productions, class actions and multidistrict litigation, generic written discovery, depositions of company executives and corporate designees, reports, depositions, and motions practice for generic experts, cross-border discovery, case-specific discovery, trials, appeals, and mass settlements with administrative follow-up.
Eric is particularly known for his work with medical and liability/regulatory experts. He has assisted in responding to government investigations and consulted with a range of pharmaceutical, medical device, and health care clients on liability and regulatory issues. Eric has been a regular speaker on litigation and product liability issues for a variety of audiences, in addition to giving formal training for co-counsel in serial litigation. Eric is also a member of the Blogging Team for the award-winning Drug and Device Law blog.
